SCHEMBL28872247

SCHEMBL28872247

CCOC(=O)C1(O)C=CC(c2cccc(Br)c2)=CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1F O60840 1/20 0.39
ABCB1 P08183 1/20 0.39
CACNA1D Q01668 1/20 0.39
CACNA1S Q13698 1/20 0.39
CACNA1C Q13936 1/20 0.39
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 1/20 0.39
ALOX5 P09917 3/20 0.38
PTGES O14684 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MAPT P10636 3/20 0.35
HPGD P15428 3/20 0.35
MAPK1 P28482 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3623072 0.85 OPRM1 (0.40) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL28676525 0.79 CACNA1F (0.35) CACNA1FABCB1CACNA1DCACNA1SCACNA1C
SCHEMBL10442548 0.76 TSHR (0.35) ALDH1A1KDM4EGAAALOX5NPC1
SCHEMBL9852431 0.72 TSHR (0.43) ALDH1A1KDM4EMAPK1LMNATP53
SCHEMBL10589794 0.72 MAPT (0.39) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL2543218 0.71 POLB (0.34) MEN1KMT2AOPRM1OPRD1SMN1; SMN2
SCHEMBL28757628 0.71 TSHR (0.41) ALDH1A1MEN1KMT2AOPRM1OPRD1
SCHEMBL1966610 0.71 OPRM1 (0.41) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL28667025 0.70 RET (0.33) CACNA1FABCB1CACNA1DCACNA1SCACNA1C
SCHEMBL27694521 0.70 CYP3A4 (0.39) CACNA1DALDH1A1KDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115246856-A Retinoic acid receptor agonist, preparation method, intermediate, pharmaceutical composition and application thereof 上海旭成医药科技有限公司 2022-10-28 CN disclosed